EGM
Engineers Gate Manager Portfolio holdings
AUM
$8.04B
1-Year Return
12.21%
This Quarter Return
+6.7%
1 Year Return
+12.21%
3 Year Return
+28.21%
5 Year Return
+42.98%
10 Year Return
+180.06%
AUM
$5.12B
AUM Growth
+$690M
(+16%)
Cap. Flow
+$411M
Cap. Flow
% of AUM
8.03%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
2,488
New
610
Increased
781
Reduced
670
Closed
420
Top Buys
| 1 |
KLA
KLAC
|
+$25.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$22.4M |
| 3 |
Elevance Health
ELV
|
+$20.9M |
| 4 |
Humana
HUM
|
+$20.3M |
| 5 |
Roblox
RBLX
|
+$20M |
Top Sells
| 1 |
PayPal
PYPL
|
+$33.9M |
| 2 |
Constellation Energy
CEG
|
+$28.3M |
| 3 |
Northrop Grumman
NOC
|
+$25.9M |
| 4 |
Starbucks
SBUX
|
+$22.2M |
| 5 |
ServiceNow
NOW
|
+$19.1M |
Sector Composition
| 1 | Technology | 20.73% |
| 2 | Industrials | 15.45% |
| 3 | Consumer Discretionary | 14.14% |
| 4 | Healthcare | 12.21% |
| 5 | Financials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
CareCloud
CCLD
$151M
| $31.5K | ﹤0.01% |
+11,921
| New | +$31.5K |
|
2002
InflaRx
IFRX
$104M
| $30.4K | ﹤0.01% |
+19,849
| New | +$30.4K |
|
2003
Esperion Therapeutics
ESPR
$512M
| $30.3K | ﹤0.01% |
+18,390
| New | +$30.3K |
|
2004
FuelCell Energy
FCEL
$118M
| $30K | ﹤0.01% |
2,631
+1,592
| +153% | +$18.1K |
|
2005
iHeartMedia
IHRT
$339M
| $29.7K | ﹤0.01% |
+16,046
| New | +$29.7K |
|
2006
Kaltura
KLTR
$238M
| $29.6K | ﹤0.01% |
+21,756
| New | +$29.6K |
|
2007
LiveOne
LVO
$56.9M
| $29.6K | ﹤0.01% |
31,164
+10,412
| +50% | +$9.88K |
|
|
QVCGA
2008
QVC Group, Inc. Series A Common Stock
QVCGA
$79M
| $28.8K | ﹤0.01% |
946
-4,005
| -81% | -$122K |
|
|
BLUE
2009
DELISTED
bluebird bio
BLUE
| $27.9K | ﹤0.01% |
+2,689
| New | +$27.9K |
|
|
SOL
2010
Emeren Group
SOL
$96.5M
| $27.6K | ﹤0.01% |
10,208
-778
| -7% | -$2.1K |
|
|
ATYR
2011
aTyr Pharma
ATYR
$520M
| $27.5K | ﹤0.01% |
+15,646
| New | +$27.5K |
|
2012
Farmer Brothers
FARM
$43.1M
| $26.7K | ﹤0.01% |
+13,502
| New | +$26.7K |
|
2013
Nerdy
NRDY
$158M
| $25.9K | ﹤0.01% |
+26,363
| New | +$25.9K |
|
2014
Xilio Therapeutics
XLO
$38.9M
| $25.8K | ﹤0.01% |
+32,752
| New | +$25.8K |
|
2015
Werewolf Therapeutics
HOWL
$62.6M
| $25K | ﹤0.01% |
+11,777
| New | +$25K |
|
2016
Passage Bio
PASG
$22.3M
| $24.3K | ﹤0.01% |
+1,739
| New | +$24.3K |
|
2017
Verrica Pharmaceuticals
VRCA
$47.8M
| $24.1K | ﹤0.01% |
+1,662
| New | +$24.1K |
|
2018
Cambium Networks
CMBM
$18.8M
| $23.9K | ﹤0.01% |
13,068
-9,334
| -42% | -$17.1K |
|
2019
Grove Collaborative
GROV
$62.3M
| $23.4K | ﹤0.01% |
+17,305
| New | +$23.4K |
|
2020
Altisource Portfolio Solutions
ASPS
$126M
| $22.7K | ﹤0.01% |
+2,362
| New | +$22.7K |
|
2021
Intellicheck
IDN
$112M
| $21.9K | ﹤0.01% |
+10,110
| New | +$21.9K |
|
2022
Sundial Growers
SNDL
$623M
| $21.4K | ﹤0.01% |
10,380
-28,341
| -73% | -$58.4K |
|
2023
CEMIG Preferred Shares
CIG
$5.78B
| $21.1K | ﹤0.01% |
10,263
-15,540
| -60% | -$32K |
|
2024
MarketWise
MKTW
$49.2M
| $20.6K | ﹤0.01% |
+1,541
| New | +$20.6K |
|
2025
PLAYSTUDIOS Inc
MYPS
$121M
| $20.5K | ﹤0.01% |
+13,574
| New | +$20.5K |
|